The global nanomedicine market was reported to be worth $70 billion by 2011, $140 billion in 2016 and is predicted to be worth $350 billion by 2025. To take advantage of the many opportunities that lie ahead and to be successful in a market that will become more and more competitive
requires an understanding of the scientific, technological, clinical, regulatory, financial and commercial challenges that apply to this field. This master class aims at describing this evolving scenario and to empower business executives and R&D expert with the necessary knowledge to navigate the entire pathway of developing, testing and commercialising new products based on nanoscale materials and to introduce them to regulatory issues, intellectual property and financing. The topics presented in this master class will provide participants with the breadth of understanding necessary to evaluate the current state of nanotechnology as well as introducing the implications of this new field in the framework of healthcare and medicine. The aim is to empower participants with the fundamental knowledge that will enable them to evaluate strategic and tactical issues and to develop problem-solving skills in the exciting and emerging discipline of nanomedicine. Finally, the master class will discuss how to progress this area to meet the future needs of the field by introducing to the participants diagnostics, therapeutics,
vaccines, implants and biosensors that have the potential to revolutionise health care.